Clinical Trials Directory

Trials / Completed

CompletedNCT05801315

Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®

Treatment of Peri-implant Mucositis: Adjunctive Benefit of Glycine Powder Air Polishing Device to Professional Mechanical Biofilm Removal. A Randomized Parallel Arm Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
University of Siena · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The aim of the present study is to evaluate the adjunctive effect of glycine-powder air-polishing (GPAP) to full-mouth ultrasonic debridement (Fm-UD) in the treatment of peri-implant mucositis, and to determine the predictive role of implant and patient-level variables for disease resolution. Both treatments are described in the literature, but few studies are available on their comparison.

Detailed description

52 patients (132 implants) with peri-implant mucositis were included in this randomized parallel arm clinical study. Following baseline variables assessment, participants received Fm-UD. Implants allocated to the test group (n=64) were additionally treated with GPAP. Clinical outcomes were evaluated at 3 and 12 months following intervention. Complete and partial disease resolution were defined as absence of BoP (DR1) or \<2 BoP+ sites (DR2), respectively.

Conditions

Interventions

TypeNameDescription
DEVICEGlycine powder air polishingPeri-implant mucositis sites treated with a glycine powder air polishing device (Air-Flow Master Piezon®).
DEVICEFull mouth ultrasonic debridementPeri-implant mucositis sites are treated with thin ultrasonic tips.

Timeline

Start date
2020-03-01
Primary completion
2023-03-20
Completion
2023-03-20
First posted
2023-04-06
Last updated
2023-07-27

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05801315. Inclusion in this directory is not an endorsement.